[Oestrogens during the menopause and the risk of endometrial carcinoma (author's transl)].
D000818:Animals; D002979:Climacteric / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D045166:Estradiol Congeners / Q000009:adverse effects / Q000627:therapeutic use*; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D011374:Progesterone / Q000627:therapeutic use; D014481:United States; D014594:Uterine Neoplasms / Q000139:chemically induced*
D045166:Estradiol Congeners; D004966:Estrogens, Conjugated (USP); D011374:Progesterone
Ostrogene im Klimakterium und Endometriumkarzinomrisiko.